Ironwood Pharmaceuticals, Inc.
Low-Dose Stable Formulations of Linaclotide

Last updated:

Abstract:

The present invention relates to stable pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well as to various methods and processes for the preparation and use of the compositions.

Status:
Application
Type:

Utility

Filling date:

18 Oct 2021

Issue date:

3 Feb 2022